CD34+ selected autologous stem cell transplantation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD34+ selected autologous stem cell transplantation, covering 2024-07-08 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: CD34+ Selected ASCT for Aggressive Lymphomas [Phase 2]